At a glance
ClinicalIndex Comparison RecordN/ACompleted· 26 enrolled
Drug / intervention
TMSdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder
In Brief
A clinical study evaluating TMS for Generalized Anxiety Disorder. Completed, enrolled 26 participants across 1 site.
Detailed Summary
This study is investigating a new indication of Transcranial Magnetic Stimulation (TMS) by conducting a pilot randomized-controlled trial (RCT) comparing structural neuronavigation-directed TMS to Sham-TMS Placebo therapy for treatment of Generalized Anxiety Disorder (GAD).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGeneralized Anxiety Disorder
CountriesUnited States
CollaboratorsNeuronetics
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2012
First PostedAug 2012
Primary CompletionDec 2014
TodayJul 2026
First PostedAug 8, 2012
Enrollment StartMay 1, 2012
Primary CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 13.9 years ago
Interventions
TMSdevice
Treatment will entail daily (5 days/week) sessions of TMS for 6 weeks.